What Is New? UPS completed the acquisition of MNX Global Logistics, a global time-critical logistics provider.
Why It Matters: The acquisition of MNX Global Logistics will expand services for healthcare customers through enhanced radio-pharma, temperature-controlled logistics, next-flight-out and expedited ground services.
UPS has completed the acquisition of MNX Global Logistics (MNX), a global time-critical logistics provider. The acquisition closed on Nov. 2, 2023, following all required regulatory approvals.
The acquisition of MNX expands UPS' capabilities of time-critical logistics, especially for healthcare customers in the US, Europe and Asia. MNX has a strong track record in providing reliable and timely delivery of critical goods. The company’s expertise in transporting radiopharmaceuticals and temperature-sensitive products will help UPS Healthcare and its clinical trial logistics subsidiary, Marken, meet the growing demand for these services in the healthcare industry. With MNX’ additional expertise, UPS will continue to offer industry-leading global service to customers who need time-critical, temperature-sensitive logistics solutions.
The acquisition of MNX is part of UPS' ongoing strategy to invest in new technologies and capabilities, providing customers with the most reliable and efficient logistics solutions possible.
Contact one of our healthcare logistics experts for more information on UPS Healthcare's innovations and customer-driven solutions.
About UPS Healthcare
UPS Healthcare delivers unparalleled healthcare logistics expertise to its customers around the world. UPS Healthcare has 11+ million square feet of cGMP and GDP-compliant healthcare distribution space globally. Its services include inventory management, cold chain packaging and shipping, storage and fulfilment of medical devices, and lab and clinical trial logistics. UPS Healthcare's global infrastructure, its UPS®Premier visibility service, its track and trace technology and its global quality system are well-suited to meet today's complex logistics demands for the pharmaceutical, medical device, and laboratory diagnostic industries.
About UPS
UPS (NYSE: UPS) is one of the world’s largest companies, with a 2022 revenue of $100.3 billion, and provides a broad range of integrated logistics solutions for customers in more than 200 countries and territories. Focused on its purpose statement, ‘Moving our world forward by delivering what matters’, the company’s more than 500,000 employees embrace a strategy that is simply stated and powerfully executed: Customer First. People Led. Innovation Driven. UPS is committed to reducing its impact on the environment and supporting the communities we serve around the world. UPS also takes an unwavering stance in support of diversity, equity and inclusion. More information can be found at www.ups.com, about.ups.com and www.investors.ups.com.
About MNX Global Logistics
MNX Global Logistics provides time-critical transportation and logistics services worldwide. Clients include multinational leaders in the biopharmaceutical, life sciences, high-tech, medical device, aviation and financial industries. These organisations rely on MNX Global Logistics to safely and securely deliver high-value, time and temperature-sensitive shipments around the world. Headquartered in Long Beach, CA, MNX Global Logistics serves 190 countries and territories. Services include Next Flight Out (NFO), Air Charter, On-Demand Courier, Managed Transportation, Service Parts Logistics (SPL) and Specialty Freight.
